Abstract:Significant heterogenity of stage IB (sixth edition of the TNM staging system) nonsmall cell lung cancer (NSCLC) has been identified, and further subclassification according to tumour size has been proposed. The aim of this study is to evaluate the prognostic factors in patients with resected stage IB NSCLC .3 cm.From January 1980 to December 2000, 525 patients underwent surgical resection for stage IB NSCLC .3 cm at Taipei Veterans General Hospital, Taipei, Taiwan. The clinicopathological characteristics of t… Show more
“…21,22 To investigate their impact on overall survival and recurrence-free survival, clinicopathologic factors were analyzed in univariate and multivariate analyses. The length of overall survival was defi ned as the interval between the date of surgical resection and the date of either death or the last follow-up.…”
Section: Methodsmentioning
confidence: 99%
“…The preoperative staging work-up was done as previously described. 21,22 All patients underwent complete resection of lung cancer with mediastinal lymph node dissection/sampling as previously described. 21,22 Histologic typing was determined according to the World Health Organization classifi cation.…”
Section: Methodsmentioning
confidence: 99%
“…21,22 All patients underwent complete resection of lung cancer with mediastinal lymph node dissection/sampling as previously described. 21,22 Histologic typing was determined according to the World Health Organization classifi cation. 23 Determination of disease stages were based on the TNM classifi cation (seventh edition) of the American Joint Committee on Cancer and the International Union Against Cancer.…”
Section: Methodsmentioning
confidence: 99%
“…18,19 Determination of VPI was done as previously described. 22 VPI was classifi ed according to the proposal of IASLC. 20 PL1 and PL2 indicate VPI and are a T2 descriptor.…”
“…21,22 To investigate their impact on overall survival and recurrence-free survival, clinicopathologic factors were analyzed in univariate and multivariate analyses. The length of overall survival was defi ned as the interval between the date of surgical resection and the date of either death or the last follow-up.…”
Section: Methodsmentioning
confidence: 99%
“…The preoperative staging work-up was done as previously described. 21,22 All patients underwent complete resection of lung cancer with mediastinal lymph node dissection/sampling as previously described. 21,22 Histologic typing was determined according to the World Health Organization classifi cation.…”
Section: Methodsmentioning
confidence: 99%
“…21,22 All patients underwent complete resection of lung cancer with mediastinal lymph node dissection/sampling as previously described. 21,22 Histologic typing was determined according to the World Health Organization classifi cation. 23 Determination of disease stages were based on the TNM classifi cation (seventh edition) of the American Joint Committee on Cancer and the International Union Against Cancer.…”
Section: Methodsmentioning
confidence: 99%
“…18,19 Determination of VPI was done as previously described. 22 VPI was classifi ed according to the proposal of IASLC. 20 PL1 and PL2 indicate VPI and are a T2 descriptor.…”
“…19,20 Mediastinoscopy was not a routine preoperative staging procedure, and was performed only when enlarged mediastinal lymph nodes (LNs) (diameter > 1.0 cm) were shown by the computed tomographic scan. 19,20 Mediastinoscopy was not a routine preoperative staging procedure, and was performed only when enlarged mediastinal lymph nodes (LNs) (diameter > 1.0 cm) were shown by the computed tomographic scan.…”
Risks of death and recurrence increase as the T descriptor upgrades in the new TNM system. The combination of risk factors can be used to identify high-risk subgroups of local recurrence and distant metastasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.